• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Filter Type Drives Polymyxin B Exposure During Continuous Renal Replacement Therapy

by
November 17, 2026
in Health
Reading Time: 3 mins read
0
Filter Type Drives Polymyxin B Exposure During Continuous Renal Replacement Therapy

Filter Type Drives Polymyxin B Exposure During Continuous Renal Replacement Therapy

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Filter membrane type is the primary determinant of polymyxin B exposure in patients undergoing continuous renal replacement therapy, exerting an effect that exceeds the influence of residual renal function or treatment intensity, according to a pharmacokinetic modeling study published in Frontiers in Pharmacology.

Existing population pharmacokinetic models for polymyxin B in individuals receiving continuous renal replacement therapy remain scarce, and prior models have consistently omitted the effect of filter membrane materials on extracorporeal drug adsorption. Although recent investigations have attempted to integrate pharmacokinetic parameters from patients not receiving extracorporeal therapy with therapy-specific data, those earlier integrated models accounted only for non-renal clearance and continuous renal replacement therapy clearance while excluding residual renal function.

To resolve these limitations, researchers constructed a literature-informed pharmacokinetic framework designed to incorporate intrinsic clearance alongside continuous renal replacement therapy clearance. In this mathematical architecture, intrinsic clearance was adjusted according to creatinine clearance to reflect residual renal function, while continuous renal replacement therapy clearance was divided into transmembrane clearance and adsorptive clearance components.

In setting the model parameters, the authors allocated adsorptive clearance to zero percent for polysulfone membranes and one hundred percent for AN69 membranes. The predictive performance of the resulting framework was subsequently evaluated using two previously published literature datasets comprising 53 and 30 patients, as well as an independent prospective cohort consisting of 10 patients.

Validation analyses demonstrated that the framework provided accurate predictions of polymyxin B exposure across both patients receiving continuous renal replacement therapy and those not receiving the therapy, maintaining a prediction error below 30 percent. Pharmacodynamic simulation analyses defined adequate target attainment as a probability of target attainment of at least 90 percent, alongside an exposure-exceedance threshold specifying that the simulated probability of an area under the curve over 24 hours exceeding 100 mg·h/L should remain at or below 14.5 percent.

Simulation results showed that dosing requirements differed substantially based on filter material for pathogens with a minimum inhibitory concentration of 0.5 mg/L. When using a polysulfone membrane with an AV600S filter, the authors determined that polymyxin B doses should be stratified based on creatinine clearance using standard or reduced dosing regimens. Conversely, for an AN69 membrane paired with an OXIRIS filter, simulations indicated that a high-dose regimen featuring a 200 mg loading dose and a 150 mg maintenance dose administered every 12 hours should be considered for infections at the same minimum inhibitory concentration.

To assist researchers in exploring these model-informed dosing decisions, the investigators established an interactive Shiny web application.

The research was conducted by investigators based in Changsha, China, representing a collaboration between the Hunan Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province at Hunan Normal University College of Life Sciences, the Department of Pharmacy at The Third Xiangya Hospital of Central South University, and the hospital’s Department of Intensive Medicine. The study team included authors Aoao Pei, Tingting Wu, Jingjing Liu, and Xing Feng, with Liu and Feng serving as corresponding authors for the project. Their work appeared in Frontiers in Pharmacology within the journal’s Pharmacology of Infectious Diseases section, following peer review after initial manuscript submission in August 2026 and subsequent acceptance in October 2026.

Subject of Research: Pharmacokinetic modeling of polymyxin B clearance and dosing during continuous renal replacement therapy

Article Title: A literature-informed pharmacokinetic framework for polymyxin B dosing during continuous renal replacement therapy: integrating renal function and extracorporeal clearance

Article References: Pei, A., Wu, T., Liu, J., & Feng, X. (2026). A literature-informed pharmacokinetic framework for polymyxin B dosing during continuous renal replacement therapy: integrating renal function and extracorporeal clearance. Frontiers in Pharmacology, 17, Article 1955923. https://doi.org/10.3389/fphar.2026.1955923

Image Credits: AI Generated

DOI: 10.3389/fphar.2026.1955923

Keywords: polymyxin B, continuous renal replacement therapy, pharmacokinetics, membrane adsorption, residual renal function, creatinine clearance, AN69 membrane, polysulfone membrane, OXIRIS filter, AV600S filter, transmembrane clearance, extracorporeal clearance, probability of target attainment, therapeutic drug monitoring, area under the curve, minimum inhibitory concentration, Shiny application

News Source: Ophelia Keating. (November 17, 2026). Filter Type Drives Polymyxin B Exposure During Continuous Renal Replacement Therapy. Scienmag.

Tags: AN69 membranearea under the curveAV600S filtercontinuous renal replacement therapycreatinine clearanceextracorporeal clearancemembrane adsorptionminimum inhibitory concentrationOXIRIS filterPharmacokineticspolymyxin Bpolysulfone membraneprobability of target attainmentresidual renal functionShiny applicationtherapeutic drug monitoringtransmembrane clearance
Share12Tweet7Share2ShareShareShare1

Related Posts

Custom-made prostheses provide functional shoulder reconstruction after scapular tumor resections

Custom-made prostheses provide functional shoulder reconstruction after scapular tumor resections

November 17, 2026
Subtle BRCA2 Gene Alterations Link to Moderate Breast Cancer Risks

Subtle BRCA2 Gene Alterations Link to Moderate Breast Cancer Risks

November 17, 2026

Review Maps Multi-System Stress Mechanisms and Clinical Limits in Takotsubo Syndrome

November 17, 2026

Talar Osteochondral Lesions Found in Most Surgically Treated Trimalleolar Ankle Patients

November 17, 2026

POPULAR NEWS

  • High Prevalence of Gender-Based Violence Follows Armed Conflict in Southern Tigray

    High Prevalence of Gender-Based Violence Follows Armed Conflict in Southern Tigray

    29 shares
    Share 12 Tweet 7
  • Air Pollutants Tied to Adverse Sleep Outcomes Amid Notable Evidence Uncertainty

    29 shares
    Share 12 Tweet 7
  • Network Analysis Identifies Core Positive Development Attributes in Rural Chinese Adolescents

    29 shares
    Share 12 Tweet 7
  • China Silver Economy Policies Show Good Overall Consistency but Uneven Regional Breadth

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Custom-made prostheses provide functional shoulder reconstruction after scapular tumor resections

Subtle BRCA2 Gene Alterations Link to Moderate Breast Cancer Risks

Degraded Tibetan Desert Steppes Show Leaf Carbon Isotope Enrichment Under Water Limitation

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.